But there is hope, as the FDA has approved almost as many new compounds in 2017 as in all of 2016.
A look at how lawsuits and FDA changes could impact the industry.
The firms all have drugs they want the feds to bend the rules to approve.
Nine biotech and drug companies want FDA approval, but need changed standards to get it.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.